Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries

被引:0
|
作者
Van Essen, GA
Palache, AM
Forleo, E
Fedson, DS
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands
[2] Solvay Pharmaceut BV, Weesp, Netherlands
[3] Vigivirus, Sao Paulo, Brazil
来源
关键词
influenza vaccination; developed countries; rapidly developing countries;
D O I
10.1016/j.ics.2004.02.164
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Influenza vaccination is becoming an increasingly important aspect of public health programs in developed and rapidly developing countries. In 2000, most of these countries had national recommendations to vaccinate elderly people and those with high-risk conditions. Levels of vaccine use, however, varied widely and several rapidly developing countries had higher levels than those seen in many developed countries. More than one-third of all influenza vaccinations occurred in countries outside North America, Western Europe and Australia and New Zealand. With increasing vaccine use, all countries will be better prepared for the next pandemic. Nonetheless, those countries that use but do not produce influenza vaccine will find it difficult to obtain supplies of pandemic vaccine. (C) 2004 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:94 / 97
页数:4
相关论文
共 50 条
  • [1] Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries
    van Essen, GA
    Palache, AM
    Forleo, E
    Fedson, DS
    VACCINE, 2003, 21 (16) : 1780 - 1785
  • [2] Influenza vaccine An effective preventive vaccine for developing countries
    Verma, Ramesh
    Khanna, Pardeep
    Chawla, Suraj
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (05) : 675 - 678
  • [3] Influenza vaccination in 22 developed countries: an update to 1995
    Fedson, DS
    Hirota, Y
    Shin, HK
    Cambillard, PE
    Kiely, J
    Ambrosch, F
    Hannoun, C
    Leese, J
    Sprenger, MJW
    Hampson, AW
    BroJorgensen, K
    Ahlbom, AM
    Nokleby, H
    Valle, M
    Olafsson, O
    Salmeron, F
    Cloetta, J
    deAndrade, HR
    Snacken, R
    Donatelli, I
    Jennings, LC
    Strikas, RA
    VACCINE, 1997, 15 (14) : 1506 - 1511
  • [4] Recommendations for the use of influenza vaccine in pediatrics
    Esposito, Susanna
    Montinaro, Valentina
    Bosis, Samantha
    Tagliabue, Claudia
    Baggi, Elena
    Principi, Nicola
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (01) : 102 - 106
  • [5] Pharmacoeconomic Analysis of Vaccination in Developed Versus Developing Countries
    McIntosh, E. David
    JOURNAL OF PEDIATRIC INFECTION, 2014, 8 (03): : 110 - 120
  • [6] Developed countries could pay for hepatitis B vaccination in developing countries
    Gay, NJ
    Edmunds, WJ
    BRITISH MEDICAL JOURNAL, 1998, 316 (7142): : 1457 - 1457
  • [7] Considerations for sustainable influenza vaccine production in developing countries
    Nannei, Claudia
    Chadwick, Christopher
    Fatima, Hiba
    Goldin, Shoshanna
    Grubo, Myriam
    Ganim, Alexandra
    VACCINE, 2016, 34 (45) : 5425 - 5429
  • [8] The Moral Case For The Routine Vaccination Of Children In Developed And Developing Countries
    Dawson, Angus
    HEALTH AFFAIRS, 2011, 30 (06) : 1029 - 1033
  • [9] COVID-19 Vaccine Challenges in Developing and Developed Countries
    Yarlagadda, Harshani
    Patel, Meet A.
    Gupta, Vasu
    Bansal, Toram
    Upadhyay, Shubekshya
    Shaheen, Nour
    Jain, Rohit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [10] INFLUENZA VACCINATION IN 18 DEVELOPED-COUNTRIES, 1980-1992
    FEDSON, DS
    HANNOUN, C
    LEESE, J
    SPRENGER, MJW
    HAMPSON, AW
    BROJORGENSEN, K
    AHLBOM, AM
    NOKLEBY, H
    VALLE, M
    OLAFSSON, O
    GARCIA, FS
    GUGELMAN, R
    DEANDRADE, HR
    SNACKEN, R
    AMBROSCH, F
    DONATELLI, I
    VACCINE, 1995, 13 (07) : 623 - 627